ADDIS ABABA – Administrating AstraZeneca COVID-19 vaccine will continue in Ethiopia as health institutions, including World Health Organization, have expressed confidence in the safety of the vaccine.
A number of European countries have halted the use of the vaccine over fears of health side effect, particularly blood clotting by some countries.
But medical exercises including European Medical Authority (EMA) are saying the benefits of getting shots into arms outweigh any potential risks.
Speaking to reporters today, Health Minister Dr. Lia Tadesse said the clinical and technical advisory groups of her office have looked into the details of AstraZeneca vaccine and assessed WHO recommendation before it decided to continue administering the vaccine.
According to her, the benefits of the AstraZeneca outweighs the stated risk of side effects by some countries.
Ethiopia will therefore continue inoculating AstraZeneca and other vaccines, the Minister added.
The East African nation has started rolling out the AstraZeneca COVID-19 vaccine, mainly to health workers on Saturday. Ethiopia has about 270,000 health work force in duty, it was learned.
The ministry plans to inoculate 20 percent Ethiopians by December, 2021.